← Back to all trials
Completed
NCT06892249
Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan
Conditions: CKD, Low Protein Dietary Intake, Malnutrition (Calorie)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 74
Sponsor: Fresenius Kabi Taiwan Ltd.
Location: Kaosiung Chang Gung Memorial Hospital Kaohsiung City
Summary
Purpose of study To evaluate suitability of two flavours of a high energy low protein formula (Renalive® LP) as oral nutritional supplement and meal replacement in chronic kidney disease stage 3b-5 outpatients Inclusion criteria (1) Diagnosed with chronic kidney disease stage 3b-5 (with history of eGFR\
Eligibility Criteria
Inclusion Criteria:
1. Diagnosed with chronic kidney disease stage 3b-5 (with history of eGFR\
Source: ClinicalTrials.gov (NCT06892249). StuddyBuddy aggregates publicly available trial information.
